Corrigendum To: “Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications” [Biomed. Pharmacother. 139 (2021) 111599] (Biomedicine & Pharmacotherapy (2021) 139, (S075333222100384x), (10.1016/J.Biopha.2021.111599))

Corrigendum To: “Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications” [Biomed. Pharmacother. 139 (2021) 111599] (Biomedicine & Pharmacotherapy (2021) 139, (S075333222100384x), (10.1016/J.Biopha.2021.111599)) Publisher Pubmed

Mohammadi E^{1, 2} ; Shafiee F³ ; Shahzamani K⁴ ; Ranjbar MM⁵ ; Alibakhshi A⁶ ; Ahangarzadeh S⁷ ; Beikmohammadi L^{8, 9} ; Shariati L^{10, 11} ; Hooshmandi S¹² ; Ataei B¹³ ; Haghjooyjavanmard S¹

Show Affiliations

1. Applied Physiology Research Center, Cardiovascular Research Institute, Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Iran
2. Core Research Facilities, Isfahan University of Medical Sciences, Isfahan, Iran
3. Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
4. Isfahan Gastroenterology and Hepatology Research Center (lGHRC), Isfahan University of Medical Sciences, Isfahan, Iran
5. Razi Vaccine and Serum Research Institute, Agricultural Research, Education, and Extension Organization (AREEO), Karaj, Iran
6. Molecular Medicine Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
7. Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
8. Department of Biochemistry, Erasmus University Medical Center, Rotterdam, Netherlands
9. Stem Cell and Regenerative Medicine Center of Excellence, Tehran University of Medical Sciences, Tehran, 14155-6559, Iran
10. Biosensor Research Center, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
11. Department of Biomaterials, Nanotechnology and Tissue Engineering, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
12. Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
13. Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Biomedicine and Pharmacotherapy Published:2021

Abstract

The authors regret the incorrect publication of affiliations of some of the authors in the original article. The correct affiliation of the authors are presented below: Elmira Mohammadia,b Fatemeh Shafieec Kiana Shahzamanid Mohammad Mehdi Ranjbare Abbas Alibakhshif Shahrzad Ahangarzadehg Leila Beikmohammadih,i Laleh Shariatij,k Soodeh Hooshmandil Behrooz Ataeim Shaghayegh HaghjooyJavanmarda a Applied Physiology Research Center, Cardiovascular Research Institute, Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Iran b Core Research Facilities, Isfahan University of Medical Sciences, Isfahan, Iran c Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran d Isfahan Gastroenterology and Hepatology Research Center (lGHRC), Isfahan University of medical sciences, Isfahan, Iran e Razi Vaccine and Serum Research Institute, Agricultural Research, Education, and Extension Organization (AREEO), Karaj, Iran f Molecular Medicine Research Center, Hamadan University of Medical Sciences, Hamadan, Iran g Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran h Department of Biochemistry, Erasmus University Medical Center, Rotterdam, The Netherlands i Stem Cell and Regenerative Medicine Center of Excellence, Tehran University of Medical Sciences, 14155-6559 Tehran, Iran j Biosensor Research Center, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran k Department of Biomaterials, Nanotechnology and Tissue Engineering, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran l Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran m Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran The authors would like to apologise for any inconvenience caused. © 2021

Experts (# of related papers)

Zahra Esfandiari (1)

Hadis Rostamabadi (1)

Style	Citing Format
MLA	Mohammadi E, et al.. "Corrigendum To: “Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications” [Biomed. Pharmacother. 139 (2021) 111599] (Biomedicine & Pharmacotherapy (2021) 139, (S075333222100384x), (10.1016/J.Biopha.2021.111599))." Biomedicine and Pharmacotherapy, vol. 140, no. , 2021, pp. -.
APA	Mohammadi E, Shafiee F, Shahzamani K, Ranjbar MM, Alibakhshi A, Ahangarzadeh S, Beikmohammadi L, Shariati L, Hooshmandi S, Ataei B, Haghjooyjavanmard S (2021). Corrigendum To: “Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications” [Biomed. Pharmacother. 139 (2021) 111599] (Biomedicine & Pharmacotherapy (2021) 139, (S075333222100384x), (10.1016/J.Biopha.2021.111599)). Biomedicine and Pharmacotherapy, 140(), -.
Chicago	Mohammadi E, Shafiee F, Shahzamani K, Ranjbar MM, Alibakhshi A, Ahangarzadeh S, Beikmohammadi L, et al.. "Corrigendum To: “Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications” [Biomed. Pharmacother. 139 (2021) 111599] (Biomedicine & Pharmacotherapy (2021) 139, (S075333222100384x), (10.1016/J.Biopha.2021.111599))." Biomedicine and Pharmacotherapy 140, no. (2021): -.
Harvard	Mohammadi E et al. (2021) 'Corrigendum To: “Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications” [Biomed. Pharmacother. 139 (2021) 111599] (Biomedicine & Pharmacotherapy (2021) 139, (S075333222100384x), (10.1016/J.Biopha.2021.111599))', Biomedicine and Pharmacotherapy, 140(), pp. -.
Vancouver	Mohammadi E, Shafiee F, Shahzamani K, Ranjbar MM, Alibakhshi A, Ahangarzadeh S, et al.. Corrigendum To: “Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications” [Biomed. Pharmacother. 139 (2021) 111599] (Biomedicine & Pharmacotherapy (2021) 139, (S075333222100384x), (10.1016/J.Biopha.2021.111599)). Biomedicine and Pharmacotherapy. 2021;140():-.
BibTex	@article{ author = {Mohammadi E and Shafiee F and Shahzamani K and Ranjbar MM and Alibakhshi A and Ahangarzadeh S and Beikmohammadi L and Shariati L and Hooshmandi S and Ataei B and Haghjooyjavanmard S}, title = {Corrigendum To: “Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications” [Biomed. Pharmacother. 139 (2021) 111599] (Biomedicine & Pharmacotherapy (2021) 139, (S075333222100384x), (10.1016/J.Biopha.2021.111599))}, journal = {Biomedicine and Pharmacotherapy}, volume = {140}, number = {}, pages = {-}, year = {2021} }
RIS	TY - JOUR AU - Mohammadi E AU - Shafiee F AU - Shahzamani K AU - Ranjbar MM AU - Alibakhshi A AU - Ahangarzadeh S AU - Beikmohammadi L AU - Shariati L AU - Hooshmandi S AU - Ataei B AU - Haghjooyjavanmard S TI - Corrigendum To: “Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications” [Biomed. Pharmacother. 139 (2021) 111599] (Biomedicine & Pharmacotherapy (2021) 139, (S075333222100384x), (10.1016/J.Biopha.2021.111599)) JO - Biomedicine and Pharmacotherapy VL - 140 IS - SP - EP - PY - 2021 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract